The PROCLAIM study, sponsored by Prevail Therapeutics, is evaluating safety and effectiveness of a one-time investigational gene therapy (PR006) intended to treat...more >
The FTD Disorders Registry and The Association for Frontotemporal Degeneration (AFTD) have developed a partnership to present educational webinars for the FTD community called “Perspectives in FTD...more >
The FTD Disorders Registry is a powerful tool in the movement to create therapies and find a cure. Together we can help change the course of the disease and put an end to FTD.
Your privacy is important! We promise to protect it. We will not share your contact information.